CASE STUDIES
Specialty drug pipeline
Leading expert insights on specialty pharmacy medications
2024 delivered notable advancements in the FDA approval of treatments for rare diseases, with 43% of all novel drug approvals classified as first-in-class and 54% designated as orphan drugs. These approvals offer new hope to patients with conditions that previously had limited therapeutic options.
Here are 10 growth driver specialty medications we are closely tracking and educating our hospital and health system partners about.
Download reportHere are 10 growth driver specialty medications we are closely tracking and educating our hospital and health system partners about.
CASE STUDIES
Driving change at hospitals & health systems
$30 million in patient assistance funding
Prior authorization time reduced to 2 days
95% PDC rate
$600 million in specialty pharmacy revenue
91% PA approval rate
PA turnaround time less than 2 days
4,524 patients served in 2 years
$288 million in specialty pharmacy revenue
Outpatient pharmacy reduced reliance on costly outsourcing
100% month-over-month average revenue growth
$31.7 million in revenue for hospital
250 prior authorizations per month, with average turnaround time of 1.4 days
“We saw distinct opportunities across patient outcomes, provider experience and financial improvement for our health system.”
Alastair Bell, MD, MBA
President and CEO of Boston Medical Center Health System
“The secret is building a team who believe in the work they do and want to create an exceptional patient experience.”
Nicole Faucher, MS
President of Clearway Health
“Through our partnerships, we seek to understand each hospital or health system’s overall strategies and create initiatives that help to support them.”
Allison Arant
Senior Vice President of Client Development and Marketing, Clearway Health
WHITE PAPERS
Innovating with specialty pharmacy clinical programs
Beyond HIV Viral Supression: The Role of Health System Specialty Pharmacists in Providing Comprehensive Care for People Living with HIV
Download paper >
Towards Eliminating Hepatitis C as a Public Health Threat in the United States
Download paper >